Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.
Manufacturers of class I medical devices considered to be consumer healthcare products will get a reprieve from complying with the U...
An advisory committee to the US Food and Drug Administration (FDA) voted unanimously to recommend a half-strength booster dose of th...
Amid concerns of a market collapse and a "grave shortage" of notified body capacity, the European Commission on Thursday proposed to...
The European Medicines Agency (EMA) has found that requiring manufacturers to replace titanium dioxide (TiO2) in medicines “will alm...
19 Oct 2021
21 Oct 2021
22 Oct 2021